From the Guidelines
For urethritis, the recommended diagnostic approach includes nucleic acid amplification tests (NAATs) for Neisseria gonorrhoeae and Chlamydia trachomatis, which are more sensitive than traditional culture techniques, as stated in the 2024 European Association of Urology guidelines 1. When evaluating a patient with urethritis, it is essential to consider the potential causes, including gonococcal urethritis (GU) and non-gonococcal urethritis (NGU), and to differentiate between them, as noted in the 2024 guidelines 1. The symptoms of urethritis, such as mucopurulent or purulent discharge, dysuria, and urethral pruritus, should be taken into account when deciding on the diagnostic approach, as mentioned in the 2002 CDC guidelines 1 and the 2024 European Association of Urology guidelines 1. Key points to consider when diagnosing urethritis include:
- Using NAATs for the detection of N. gonorrhoeae and C. trachomatis, as recommended in the 2024 guidelines 1
- Collecting urethral swabs or urine samples before urination, ideally at least 1-2 hours after the patient's last void, as suggested in the example answer
- Considering additional testing for Trichomonas vaginalis, Mycoplasma genitalium, and Ureaplasma urealyticum in persistent cases, as mentioned in the 2024 guidelines 1
- Initiating empiric treatment with ceftriaxone and doxycycline while awaiting culture results, as recommended in the example answer, to prevent complications like epididymitis, prostatitis, pelvic inflammatory disease, and transmission to partners. Proper specimen collection is crucial for accurate results, and poor technique can lead to false negatives, highlighting the importance of following guidelines and recommendations, such as those outlined in the 2024 European Association of Urology guidelines 1.
From the FDA Drug Label
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. Appropriate culture and susceptibility tests should be performed before treatment to determine the causative organism and its susceptibility to azithromycin. Appropriate culture and susceptibility tests should be performed before treatment to determine the causative organism and its susceptibility to doxycycline.
Culture for urethritis is recommended before treatment with azithromycin 2 or doxycycline 3 to determine the causative organism and its susceptibility to the drug.
- Key points:
- Culture and susceptibility tests should be performed before treatment.
- Therapy may be initiated before results of these tests are known.
- Antimicrobial therapy should be adjusted accordingly once the results become available.
From the Research
Culture for Urethritis
- Urethritis refers to inflammation of the urethra and is classified as gonococcal or nongonococcal in origin 4
- The most common signs and symptoms include dysuria, mucopurulent urethral discharge, urethral discomfort, and erythema 4
- Diagnostic criteria include typical signs, symptoms, or history of exposure in addition to mucopurulent discharge, Gram stain of urethral secretions showing at least two white blood cells per oil immersion field, first-void urinalysis showing at least 10 white blood cells per high-power field, or a positive leukocyte esterase result with first-void urine 4
Diagnosis and Treatment
- First-line empiric treatment consists of ceftriaxone and doxycycline; however, the antibiotic regimen may be targeted to the isolated organism 4
- The combination of azithromycin or doxycycline plus ceftriaxone or cefixime is considered first-line empiric therapy in patients with urethritis 5
- A single intramuscular injection of ceftriaxone, 250 mg, is first-line treatment for uncomplicated urogenital, anorectal, or pharyngeal gonococcal infections 6
- Uncomplicated gonococcal infection should be treated with a single 500-mg dose of intramuscular ceftriaxone in people weighing less than 331 lb (150 kg) 7
Screening and Prevention
- All sexually active people with a cervix who are younger than 25 years and older people with a cervix who have risk factors should be screened annually for chlamydial and gonococcal infections 7
- Sexually active men who have sex with men should be screened at least annually 7
- Patients treated for urethritis should abstain from sex for seven days after the start of treatment, until their partners have been adequately treated, and until their symptoms have fully resolved 4
- Condom use is an effective strategy to reduce the risk of infection 6